RIGEL PHARMACEUTICALS INC — Director's Dealing 2017

Nov 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2017-11-03

Reporting Person: Maynard Ryan D (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-03	Common Stock	M	100000	$2.14	Acquired	100000	Direct
2017-11-03	Common Stock	S	100000	$3.90	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-03	Employee Stock Option (right to buy)	$2.14	M	100000	Disposed	2025-01-26	Common Stock (100000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2017.

F2: The option vested monthly over two years from January 1, 2015.